High Doses of Colchicine Act As "Silver Bullets" Against Severe COVID-19

被引：7

作者：

Lilov, Alexander ^{[1
]}

Palaveev, Kiril ^{[1
]}

Mitev, Vanyo ^{[2
]}

机构：

[1] Sofia Dist Hosp, Specialized Hosp Act Treatment Pneumopneumonia Pht, Pulmonol, Sofia, Bulgaria

[2] Med Univ Sofia, Chem & Biochem, Sofia, Bulgaria

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2024年 / 16卷 / 02期

关键词：

obesity; survival; colchicine; nlrp3; inflammasome; covid-19;

D O I：

10.7759/cureus.54441

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 48-year-old patient with a weight of 120 kg with type 2 diabetes mellitus, hypertension, and gout was hospitalized on the third day of the COVID-19 diagnosis. His general condition is relatively good, oxygen saturation is 89%. Despite starting standard treatment, on the seventh day from the onset of symptoms, the patient deteriorated sharply (oxygen saturation dropped to 74%). The negative development of the disease is interrupted with a loading dose of colchicine of 6 mg. This is a typical case of the life-saving effect of high but safe doses of colchicine in high-risk COVID-19 patients.

引用

页数：8

共 50 条

[31] Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial
Perricone, Carlo
Scarsi, Mirko
Brucato, Antonio
Pisano, Paola
Pigatto, Erika
Becattini, Cecilia
Cingolani, Antonella
Tiso, Francesco
Prota, Roberto
Tomasoni, Lina Rachele
Cutolo, Maurizio
Tardella, Marika
Rozza, Davide
Zerbino, Carlo
Andreoni, Massimo
Poletti, Venerino
Bartoloni, Elena
Gerli, Roberto
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 107 : 30 - 36
[32] Improved kidney function is associated with Colchicine treatment in COVID-19 patients
Bayram, Yeter Eylul
Bardakci, Mustafa Ilteris
Albayrak, Gulhan Ayhan
BMC NEPHROLOGY, 2024, 25 (01)
[33] Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19
Tardif, Jean-Claude
Cossette, Marieve
Guertin, Marie-Claude
Bouabdallaoui, Nadia
Dube, Marie-Pierre
Boivin, Guy
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : 387 - 390
[34] Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19?
Santa, Sheila
Doku, Derek A.
Olwal, Charles O.
Brown, Charles A.
Tagoe, Emmanuel A.
Quaye, Osbourne
FUTURE MICROBIOLOGY, 2022, 17 (10) : 803 - 812
[35] Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial
Landi, Antonio
Morici, Nuccia
Vranckx, Pascal
Frigoli, Enrico
Bonacchini, Luca
Omazzi, Barbara
Tresoldi, Moreno
Camponovo, Claudio
Moccetti, Tiziano
Valgimigli, Marco
JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (12) : 920 - 930
[36] Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
Al-kuraishy, Hayder M.
Al-Gareeb, Ali, I
Qusty, Naeem
Cruz-Martins, Natalia
Batiha, Gaber El-Saber
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 67
[37] Successful Treatment With High-Dose Colchicine of a 101-Year-Old Patient Diagnosed With COVID-19 After an Emergency Cholecystectomy
Bulanov, Dimitar
Yonkov, Atanas
Arabadzhieva, Elena
Mitev, Vanyo
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
[38] Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease
Bansal, Devendra
Abdulmajeed, Jazeel
Al-Shamali, Maha H. M. A.
Albayat, Soha S. A.
Himatt, Sayed M.
Cyprian, Farhan S.
Chivese, Tawanda
Mundodan, Jesha M. A.
Khogali, Hayat S.
Baaboura, Rekayahouda
Kaleeckal, Anvar H.
Kandy, Mujeeb C.
Latif, Ali Nizar
Al-Kuwari, Mohamed Ghaith
Al-Romaihi, Hamad Eid
Al Khal, Abdullatif
Bertollini, Roberto
Al-Thani, Mohamed Hamad
Farag, Elmobashar
Doi, Suhail A. R.
VACCINES, 2022, 10 (07)
[39] Hypertension and severe COVID-19
Chia Siang Kow
Dinesh Sangarran Ramachandram
Syed Shahzad Hasan
Hypertension Research, 2023, 46 : 1353 - 1354
[40] The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?
Cai, Pengfei
Mu, Yi
McManus, Donald P.
FRONTIERS IN IMMUNOLOGY, 2022, 13

← 1 2 3 4 5 →